Difficulty: Medium
Average Score: 91%
Practice
A 61-year-old man with hypertension develops atrial fibrillation. His medications include simvastatin and metoprolol. His physician prescribes an anticoagulant for clot prophylaxis, which directly inhibits thrombin. Which drug is this?
Correct answer
B
Rationale
In this scenario, the correct answer is B) Dabigatran. Dabigatran is a direct thrombin inhibitor, commonly used for stroke prevention in patients with atrial fibrillation. It works by specifically targeting thrombin, which plays a crucial role in the coagulation cascade. In contrast, the other options are not direct thrombin inhibitors.
A) Aspirin is an antiplatelet agent that inhibits cyclooxygenase, thereby preventing platelet aggregation. It is not a direct thrombin inhibitor.
C) Heparin works by enhancing antithrombin III activity, leading to the inactivation of thrombin and other clotting factors. While it is an anticoagulant, it does not directly inhibit thrombin like dabigatran.
D) Ticlopidine is an antiplatelet agent that inhibits platelet aggregation by preventing ADP-mediated activation. It does not directly inhibit thrombin.
In an educational context, understanding the mechanisms of action of different anticoagulants is crucial for healthcare professionals managing patients with cardiovascular conditions. Knowing the specific targets of each medication helps in making appropriate treatment decisions based on individual patient characteristics and clinical scenarios. This knowledge also aids in preventing medication errors and optimizing patient outcomes.
A) Aspirin is an antiplatelet agent that inhibits cyclooxygenase, thereby preventing platelet aggregation. It is not a direct thrombin inhibitor.
C) Heparin works by enhancing antithrombin III activity, leading to the inactivation of thrombin and other clotting factors. While it is an anticoagulant, it does not directly inhibit thrombin like dabigatran.
D) Ticlopidine is an antiplatelet agent that inhibits platelet aggregation by preventing ADP-mediated activation. It does not directly inhibit thrombin.
In an educational context, understanding the mechanisms of action of different anticoagulants is crucial for healthcare professionals managing patients with cardiovascular conditions. Knowing the specific targets of each medication helps in making appropriate treatment decisions based on individual patient characteristics and clinical scenarios. This knowledge also aids in preventing medication errors and optimizing patient outcomes.